Slowing of brain atrophy with Teriflunomide
Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite Multiple sclerosis.
.jpg1/jcr:content/image%20(40).jpg)
.jpg1/jcr:content/ms-podcasts-new-thumb%20(1).jpg)
.jpg0/jcr:content/ms-podcasts-new-thumb%20(1).jpg)
MAT-BH-2200911-Nov 22
Campus
Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite Multiple sclerosis.
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.